HeartMate II Ventricular Assist Device Thrombosis—An Echocardiographic Approach to Diagnosis: Can Doppler Evaluation of Flow Be Useful?

• Published in: Journal of the American Society of Echocardiography Vol. 24; no. 3; pp. 350.e1 - 350.e4
• Main Authors: Paluszkiewicz, Lech, MD, Gürsoy, Dilek, MD, Spiliopoulos, Sotirios, MD, Dogan, Günes, MD, Daliakopoulos, Stavros, MD, Tenderich, Magda, MD, Körfer, Reiner, MD, PhD, Tenderich, Gero, MD, PhD
• Format: Journal Article
• Language: English
• Published: United States Mosby, Inc 01.03.2011
• Subjects: Aged; Cardiovascular; Echocardiography; Echocardiography - methods; Heart-Assist Devices - adverse effects; HeartMate II; Humans; Male; Thrombosis - diagnostic imaging; Thrombosis - etiology; Thrombosis - therapy; Ventricular assist device; Ventricular Dysfunction, Left - diagnostic imaging; Ventricular Dysfunction, Left - etiology; Ventricular Dysfunction, Left - prevention & control; HeartMate II; Ventricular assist device; Echocardiography
• ISSN: 0894-7317; 1097-6795
• DOI: 10.1016/j.echo.2010.06.007

A 68-year-old man was admitted to the hospital 4 months after HeartMate II ventricular assist device implantation, because his clinical status had deteriorated and his levels of lactate dehydrogenase and free hemoglobin had increased. Transthoracic echocardiography performed at admission revealed decreased basic diastolic continuous flow velocity with a pulsatile increase in flow velocity during ventricular contraction in both inflow and outflow cannulas. Twelve hours after beginning lytic therapy, basal diastolic continuous flow velocity had increased, and the amplitude between diastolic and systolic flow velocity had decreased. The clinical status of the patient improved, and his lactate dehydrogenase decreased. A decrease in basal diastolic flow may be a valuable marker of flow disturbance in continuous flow ventricular assist devices.